Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$103.94 - $118.98 $2.08 Million - $2.38 Million
19,965 New
19,965 $2.13 Million
Q4 2023

Feb 12, 2024

BUY
$114.26 - $136.0 $2.02 Million - $2.41 Million
17,717 New
17,717 $2.18 Million
Q1 2021

May 14, 2021

SELL
$150.19 - $173.5 $7,509 - $8,675
-50 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $7,035 - $8,252
50 New
50 $7,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.